Analyst picks & changes

Amgen Inc.

Dillon, Read analyst Larry Bloom upgraded Amgen Inc. to "attractive" from "neutral," saying

Neupogen

G-CSF sales have recovered in the past

Read the full 237 word article

How to gain access

Continue reading with a
two-week free trial.